<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">IJCM</journal-id><journal-title-group><journal-title>International Journal of Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2158-284X</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ijcm.2020.1110049</article-id><article-id pub-id-type="publisher-id">IJCM-103577</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  The Influence of Kidney Stones and Salivary Uric Acid on Dental Calculus Formation and Periodontal Status among Some Saudi Patients Aged 25 - 70 Years
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mohammed</surname><given-names>M. A. Abdullah Al-Abdaly</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Fayez</surname><given-names>Saud Thlaab Alharbi</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ali</surname><given-names>Mohammed Almoalem</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Nasser</surname><given-names>Ahmed Taib Awaji</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>College of Dentistry, King Khalid University, Abha, Saudi Arabia</addr-line></aff><aff id="aff1"><addr-line>Periodontics and Community Dental Sciences Department, College of Dentistry, King Khalid University, Abha, Saudi Arabia</addr-line></aff><pub-date pub-type="epub"><day>20</day><month>10</month><year>2020</year></pub-date><volume>11</volume><issue>10</issue><fpage>565</fpage><lpage>578</lpage><history><date date-type="received"><day>25,</day>	<month>September</month>	<year>2020</year></date><date date-type="rev-recd"><day>19,</day>	<month>October</month>	<year>2020</year>	</date><date date-type="accepted"><day>22,</day>	<month>October</month>	<year>2020</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Background: The formation of kidney stones is considered a complicated process. Consequently, there are many questions about the link between kidney stones formation and level of salivary uric acid and calculus formation on the teeth surfaces. 
  Objectives: To evaluate the correlation between the level of salivary uric acid and kidney stones formation and their influence on dental calculus and periodontal status among Saudi patients aged 25 - 70 years. 
  Materials and Methods: 120 Saudi male patients were examined (60 of Kidney stones patients and 60 patients of non-kidney stones patients) for clinical evaluation of plaque index (PLI), gingival index (GI), calculus index of oral hygiene (CI) and clinical attachment loss (CAL). Moreover, lab assessment of uric acid level in the collected salivary samples was done. The findings were analyzed using of ANOVA test and Tukey’s test. 
  Results: There were statistically significant differences in clinical parameters among kidney stones patients and non-kidney stones patients (p &lt; 0.05), but these differences were highly statistically significant in the correlation between calculus index (CI), plaque index (PLI) and gingival index (GI) among kidney stone patients in group II, moreover, PLI and clinical attachment loss (CAL) among kidney stone patients in group III (p &lt; 0.001). The statistical analyses revealed statistically significant differences in the level of salivary uric acid (mg/dl) in the comparison between kidney stones patients and non-kidney stones patients in group I and group III, whereas there were highly statistically significant in the comparison between kidney stones patients and non-kidney stones patients in group III. 
  Conclusion: At the end of this study, we concluded that there was a relationship between dental calculus formation, kidney stones formation, and an increase in the level of salivary uric acid.
 
</p></abstract><kwd-group><kwd>Dental Calculus</kwd><kwd> Kidney Stones</kwd><kwd> Uric Acid</kwd><kwd> Periodontal Status</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>The oral cavity is a part of the body that includes various microorganisms, which subsist as a normal community of complex biofilms, structurally organized and multispecies [<xref ref-type="bibr" rid="scirp.103577-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.103577-ref2">2</xref>]. Therefore, it may be an effective method for the assessment of general and oral health [<xref ref-type="bibr" rid="scirp.103577-ref3">3</xref>].</p><p>On the other hand, Saliva is the main liquid in the oral cavity and is essential to keep the oral tissues in healthy status by inhibiting proliferation specific microorganisms, and moreover, inhibiting the build-up of dental plaque and dental calculus [<xref ref-type="bibr" rid="scirp.103577-ref4">4</xref>]. Consequently, saliva may be considered a mirror that can reflect the normal and abnormal states of the body [<xref ref-type="bibr" rid="scirp.103577-ref3">3</xref>].</p><p>The anti-oxidative system in saliva includes different enzymes and molecules which are periodontal biomarkers in the evaluation of the periodontal status [<xref ref-type="bibr" rid="scirp.103577-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.103577-ref6">6</xref>]. Uric acid participates in the antioxidant ability of saliva and blood. Further, it forms nearly 70% - 85% of this ability in the saliva of healthy and periodontitis patients [<xref ref-type="bibr" rid="scirp.103577-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.103577-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.103577-ref9">9</xref>]. According to previous studies, there was a possible effect of uric acid and other antioxidants in periodontal disease initiation and progression in addition to uric acid association with some systemic abnormality such as kidney stones formation [<xref ref-type="bibr" rid="scirp.103577-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.103577-ref11">11</xref>].</p><p>A kidney stone is one of the most prevalent systemic diseases of current communities and infects 12% - 15% of the population, and calcium oxalate stones are considered the dominant type of kidney stones worldwide [<xref ref-type="bibr" rid="scirp.103577-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.103577-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.103577-ref14">14</xref>]. The possibility of kidney stones recurrence is approximately 10% - 50% through 1 - 5 years from the first infects of kidney stones [<xref ref-type="bibr" rid="scirp.103577-ref15">15</xref>]. In Saudi Arabia, the dehydration and hot weather are reflecting on the estimation of kidney stone risk on the life where the kidney stone incident is at least 50% more than the western countries and, up to 90% of these patients exhibit abnormal oral changes [<xref ref-type="bibr" rid="scirp.103577-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.103577-ref17">17</xref>].</p><p>Dental calculus is the mineralization of dental plaque on the natural tooth surfaces and dental prosthesis in the mouth. Moreover, it has the same biological system of the structure formation process of kidney stones and according to the place of calculus, there are supra and subgingival calculus that are covered by unmineralized dental plaque which is the main etiologic factor of periodontal diseases [<xref ref-type="bibr" rid="scirp.103577-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.103577-ref19">19</xref>] [<xref ref-type="bibr" rid="scirp.103577-ref20">20</xref>] due to the sharing of kidney stones and dental calculus in the process of calcification and formation factors. Also, there was no prior Saudi study found carrying out among patients from Aseer region to evaluate the influence of kidney stones and salivary uric acid on dental calculus formation and periodontal status among some Saudi patients aged 25 - 70 years. Therefore, the present study was designed for the assessment of these objectives [<xref ref-type="bibr" rid="scirp.103577-ref21">21</xref>].</p></sec><sec id="s2"><title>2. Materials and Methods</title><sec id="s2_1"><title>2.1. Ethical Clearance</title><p>The current retrospective study carried out at the outpatients’ clinics, college of dentistry, King Khalid University between March 2020 G and August 2020 G. The research proposal was approved by the scientific research committee, college of dentistry, King Khalid University. The objectives of the study were fully exhibited to the patients at the beginning of this study, and the patients’ informed consent was obtained to fulfill ethical clearance (IRB/KKUCOD/ETH/2019-20/039). The sample size of the study was identified according to the number of patients who come to the outpatients’ clinics, the college of dentistry, King Khalid University through the study duration. The G*Power software program was used for performing the sample size calculation [<xref ref-type="bibr" rid="scirp.103577-ref22">22</xref>].</p><p>The patients’ data related to the patient name, age, gender, and general health were collected from the medical files of the patients. Furthermore, we asked the patients about oral hygiene measures, bad oral habits, and the presence or absence of xerostomia.</p></sec><sec id="s2_2"><title>2.2. Participant Selection</title><p>According to the proposal of this study, a total of 120 Saudi males patients interviewed 60 patients (study group) diagnosed as kidney stones patients based on radiographs and general urine investigations, and 60 patients were diagnosed without kidney stones based on ultrasound in the latter three months (control group). All patients were examined clinically to evaluate the amount of dental calculus and periodontal status; moreover, the salivary uric acid level was measured. The patients were divided according to the ages into three equal groups (n = 40): (Group I) 25 - 40 years, (Group II) 41 - 55 years, and (Group III) 56 - 70 years. All groups included two equal subgroups (n = 20). The subgroups comprised 20 kidney stones patients as study subgroups and 20 healthy patients (non-kidney stones) as the control subgroup.</p></sec><sec id="s2_3"><title>2.3. Inclusion and Exclusion Criteria</title><p>The patients of the study group were without other systemic diseases and, the size of the kidney stone was 20 mm. They were using tooth brushing but did not visit the dental clinics for calculus removal since one year ago. They did not wear orthodontic appliances or fixed or removable dental prostheses. Moreover, they were in a fasting status, whereas the patients of the control group were of good medical status.</p><p>The exclusion criteria were the patients who received periodontal therapy within the past 6 months, the patients with bone disease, endocrine disease, blood diseases, medically compromised patients, alcoholic patients, the patients with vitamin D deficiency, and who need calcium supplements. The comprehensive kidney function evaluation was obtained from patients’ medical reports that were within the patients’ files to exclude any patients with other kidney diseases.</p></sec><sec id="s2_4"><title>2.4. Clinical Examination</title><p>Periodontal examination was done by the assessment of plaque index (PLI) [<xref ref-type="bibr" rid="scirp.103577-ref23">23</xref>], gingival index (GI) [<xref ref-type="bibr" rid="scirp.103577-ref24">24</xref>], calculus index of oral hygiene index (CI) [<xref ref-type="bibr" rid="scirp.103577-ref25">25</xref>] and, clinical attachment loss (CAL). All clinical parameters were recorded by a Williams probe with a diameter of 0.5 mm (Hu-FriedyIns Co., USA) of each tooth except third molar teeth. PLI, GI, and CI were assessed on mesio-buccal, buccal, disto-buccal, and lingual or palatal, whereas CAL was assessed in interdental areas according to the last classification of periodontal diseases [<xref ref-type="bibr" rid="scirp.103577-ref26">26</xref>] [<xref ref-type="bibr" rid="scirp.103577-ref27">27</xref>] [<xref ref-type="bibr" rid="scirp.103577-ref28">28</xref>]. PLI was recorded before the collection of saliva samples. The clinical findings were recorded in particular case sheets and charts.</p></sec><sec id="s2_5"><title>2.5. Salivary Collection of Saliva and Biochemical Investigations</title><p>The samples of un-stimulated saliva were obtained in the morning after breakfast (9-11 am) to reduce circadian changes. The patients were demanded to swallow of saliva and stay stable 10 min for collection of saliva into a sterilized plastic. The samples were transported on dry ice within less than 30 min for lab investigation after stored at −70˚C. The experiment of saliva collection was conducted by the Modified Navazesh method [<xref ref-type="bibr" rid="scirp.103577-ref29">29</xref>]. A centrifuge was used at 4000 g for 10 minutes at room temperature to remove cell debris, and an Erba kit was applied as an enzymatic method to identify uric acid.</p></sec><sec id="s2_6"><title>2.6. Statistical Analysis</title><p>Statistical analyses of this study were done by ANOVA test for an account and, demonstrate the mean and standard deviation of the clinical results, and biochemical investigations findings. The scale of significance was assessed by using Tukey’s test, and it was acceptable at P &lt; 0.05, and highly significant when P &lt; 0.01.</p></sec></sec><sec id="s3"><title>3. Results</title><p>The present study included a total of 120 male Saudi patients (50% kidney stones patients and 50% non-kidney stones patients) into three different age groups. The distribution of patients as kidney stones patients or non-kidney stones patients within the study groups as subgroups, which appears in <xref ref-type="table" rid="table1">Table 1</xref> and <xref ref-type="fig" rid="fig1">Figure 1</xref>. <xref ref-type="table" rid="table1">Table 1</xref> and <xref ref-type="fig" rid="fig1">Figure 1</xref> illustrate the age distribution and the mean of age among study groups. The mean age for non-kidney stones patients was 32.01 ys and 31.22 ys for kidney stones patients in group I. Moreover, it was 49.3 ys for non-kidney stones patients and 51.1 ys for kidney stones patients in group II, whereas it was 63.51 ys for non-kidney stones patients and 65.87 ys for kidney stones patients in group III. There were statistically significant differences in the ages between groups I, II, and III (p &lt; 0.05) but, there were no statistically significant differences in the age between non-kidney stones patients and kidney stones patients in this study (p &gt; 0.05).</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Age distribution and the mean of age among study groups</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Groups</th><th align="center" valign="middle"  rowspan="2"  >Range</th><th align="center" valign="middle"  rowspan="2"  >No</th><th align="center" valign="middle"  colspan="2"   rowspan="2"  >Mean &#177; SD</th><th align="center" valign="middle"  colspan="2"  >ANOVA</th><th align="center" valign="middle"  colspan="3"  >Tukey’s test</th></tr></thead><tr><td align="center" valign="middle" >F</td><td align="center" valign="middle" >P-value</td><td align="center" valign="middle" >I&amp;II</td><td align="center" valign="middle" >I&amp;III</td><td align="center" valign="middle" >II&amp;III</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >GI</td><td align="center" valign="middle"  rowspan="2"  >25 - 40 ys</td><td align="center" valign="middle"  rowspan="2"  >40</td><td align="center" valign="middle" >N-KS</td><td align="center" valign="middle" >32.01 &#177; 8.11</td><td align="center" valign="middle"  rowspan="6"  >4. 322</td><td align="center" valign="middle"  rowspan="6"  >0.031</td><td align="center" valign="middle"  rowspan="6"  >0.021</td><td align="center" valign="middle"  rowspan="6"  >0.013</td><td align="center" valign="middle"  rowspan="6"  >0.040</td></tr><tr><td align="center" valign="middle" >KS</td><td align="center" valign="middle" >31.22 &#177; 4</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >G II</td><td align="center" valign="middle"  rowspan="2"  >41 - 55 ys</td><td align="center" valign="middle"  rowspan="2"  >40</td><td align="center" valign="middle" >N-KS</td><td align="center" valign="middle" >49.3 &#177; 2.46</td></tr><tr><td align="center" valign="middle" >KS</td><td align="center" valign="middle" >51.1 &#177; 4.21</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >G III</td><td align="center" valign="middle"  rowspan="2"  >56 - 70 ys</td><td align="center" valign="middle"  rowspan="2"  >40</td><td align="center" valign="middle" >N-KS</td><td align="center" valign="middle" >63.51 &#177; 6.32</td></tr><tr><td align="center" valign="middle" >KS</td><td align="center" valign="middle" >65.87 &#177; 9.71</td></tr><tr><td align="center" valign="middle" >N-KS</td><td align="center" valign="middle" >25 - 70 ys</td><td align="center" valign="middle" >60</td><td align="center" valign="middle"  colspan="2"  >48.27 &#177; 5.63</td><td align="center" valign="middle"  rowspan="2"  >1.712</td><td align="center" valign="middle"  rowspan="2"  >0.186</td><td align="center" valign="middle"  colspan="3"   rowspan="2"  >0.563</td></tr><tr><td align="center" valign="middle" >KS</td><td align="center" valign="middle" >25 - 70 ys</td><td align="center" valign="middle" >60</td><td align="center" valign="middle"  colspan="2"  >49.39 &#177; 5.97</td></tr></tbody></table></table-wrap><p>G: group, No: Number of participants, SD: Standard deviation, N-KS: non-Kidney stones, KS: Kidney stones.</p><p>When we asked the patients about the self-plaque control, the feeling of dry mouth, and bad oral habits, just 45% of kidney stones patients reported that they used a toothbrush in self plaque control compared to 55% of non-kidney stones patients. Moreover, 87% of kidney stones patients were feeling of dry mouth and 13% of non-kidney stones patients clarified that there were no feeling of dry mouth. Opposite we detected in the patients’ answers that 78% of patients were smokers (50% kidney stones patients and 50% non-kidney stones patients).</p><p>Regarding the comparison of groups I, II and, II in clinical parameter values. There were statistically significant differences in PLI and CI among the kidney stone patients plus GI and CI among non-kidney stones patients (p &lt; 0.05), whereas there were no statistically significant differences in GI and CAL among the kidney stones patients moreover PLI and CAL among non-kidney stones patients (p &gt; 0.05) (<xref ref-type="table" rid="table2">Table 2</xref> and <xref ref-type="fig" rid="fig2">Figure 2</xref>).</p><p>On the other hand, there were statistically significant differences in PLI, GI, CI and CAL in the comparison between group I, II the kidney stones patients (p &lt; 0.05) vice versa in non-kidney stones patients where there were no statistically significant differences in PLI, GI, CI, and CAL (p &gt; 0.05) and also there were statistically significant differences between group I and III in PLI, GI, CI, and CAL among kidney stones patients moreover, PLI and GI among non-kidney stones patients (p &lt; 0.05), whereas we did not find statistically significant differences in CI and CAL among non-kidney stones patients (p &gt; 0.05). Furthermore, there were no statistically significant differences between group II and III in all clinical parameters except CI among non-kidney stones patients (p &gt; 0.05).</p><p>In this study, the correlation between clinical parameters with CI of all patients was analyzed by ANOVA test (<xref ref-type="table" rid="table3">Table 3</xref>). Significant statistically significant differences between clinical parameters and CI were observed among kidney stones patients and non-kidney stones patients (p &lt; 0.05), but these differences were highly statistically significant in the correlation between CI and PLI and GI among kidney stones patients in group II moreover, PLI and CAL among kidney stones patients in group III (p &lt; 0.001).</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Clinical findings</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="2"   rowspan="2"  >CP</th><th align="center" valign="middle"  colspan="3"  >Groups</th><th align="center" valign="middle"  colspan="2"  >ANOVA</th><th align="center" valign="middle"  colspan="3"  >Tukey’s test</th></tr></thead><tr><td align="center" valign="middle" >GI</td><td align="center" valign="middle" >GII</td><td align="center" valign="middle" >GIII</td><td align="center" valign="middle" >F</td><td align="center" valign="middle" >P-value</td><td align="center" valign="middle" >I&amp;II</td><td align="center" valign="middle" >I&amp;III</td><td align="center" valign="middle" >II&amp;III</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >PLI</td><td align="center" valign="middle" >N-KS</td><td align="center" valign="middle" >1.8 &#177; 0.2</td><td align="center" valign="middle" >1.6 &#177; 0,6</td><td align="center" valign="middle" >2.1 &#177; 0.4</td><td align="center" valign="middle" >2.322</td><td align="center" valign="middle" >0.115</td><td align="center" valign="middle" >0.112</td><td align="center" valign="middle" >0.001</td><td align="center" valign="middle" >0.279</td></tr><tr><td align="center" valign="middle" >KS</td><td align="center" valign="middle" >2.25 &#177; 1.2</td><td align="center" valign="middle" >2.2 &#177; 0.7</td><td align="center" valign="middle" >2.7 &#177; 1.1</td><td align="center" valign="middle" >1.499</td><td align="center" valign="middle" >0.044</td><td align="center" valign="middle" >0.011</td><td align="center" valign="middle" >0.002</td><td align="center" valign="middle" >0.232</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >GI</td><td align="center" valign="middle" >N-KS</td><td align="center" valign="middle" >1.9 &#177; 0.6</td><td align="center" valign="middle" >1.4 &#177; 0.5</td><td align="center" valign="middle" >2 &#177; 0.3</td><td align="center" valign="middle" >1.014</td><td align="center" valign="middle" >0.050</td><td align="center" valign="middle" >0.498</td><td align="center" valign="middle" >0.003</td><td align="center" valign="middle" >0.081</td></tr><tr><td align="center" valign="middle" >KS</td><td align="center" valign="middle" >2.15 &#177; 0.4</td><td align="center" valign="middle" >2.3 &#177; 0.9</td><td align="center" valign="middle" >2.2 &#177; 0.4</td><td align="center" valign="middle" >1.55</td><td align="center" valign="middle" >0.722</td><td align="center" valign="middle" >0.001</td><td align="center" valign="middle" >0.006</td><td align="center" valign="middle" >0.356</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >CI</td><td align="center" valign="middle" >N-KS</td><td align="center" valign="middle" >1.6 &#177; 0.2</td><td align="center" valign="middle" >1.3 &#177; 0.6</td><td align="center" valign="middle" >1.8 &#177; 0.4</td><td align="center" valign="middle" >1.662</td><td align="center" valign="middle" >0.000</td><td align="center" valign="middle" >0.077</td><td align="center" valign="middle" >0.336</td><td align="center" valign="middle" >0.014</td></tr><tr><td align="center" valign="middle" >KS</td><td align="center" valign="middle" >1.9 &#177; 0.4</td><td align="center" valign="middle" >2.0 &#177; 05</td><td align="center" valign="middle" >2.2 &#177; 0.4</td><td align="center" valign="middle" >3.618</td><td align="center" valign="middle" >0.001*</td><td align="center" valign="middle" >0.004</td><td align="center" valign="middle" >0.000</td><td align="center" valign="middle" >0.315</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >CAL</td><td align="center" valign="middle" >N-KS</td><td align="center" valign="middle" >2.8 &#177; 1.6</td><td align="center" valign="middle" >2.9 &#177; 1.5</td><td align="center" valign="middle" >2.8 &#177; 1.8</td><td align="center" valign="middle" >1.148</td><td align="center" valign="middle" >0.863</td><td align="center" valign="middle" >0.133</td><td align="center" valign="middle" >0.622</td><td align="center" valign="middle" >0.091</td></tr><tr><td align="center" valign="middle" >KS</td><td align="center" valign="middle" >3.8 &#177; 1.2</td><td align="center" valign="middle" >4.35 &#177; 0.7</td><td align="center" valign="middle" >4.7 &#177; 0.6</td><td align="center" valign="middle" >4.47</td><td align="center" valign="middle" >0.465</td><td align="center" valign="middle" >0.033</td><td align="center" valign="middle" >0.000</td><td align="center" valign="middle" >0.420</td></tr></tbody></table></table-wrap><p>PLI: Plaque index, GI: Gingival index, CI: Calculus index, CAL: Clinical attachment loss.</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Correlation in clinical parameters with calculus index of all patients with ANOVA test</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Groups</th><th align="center" valign="middle"  rowspan="2"  >CP</th><th align="center" valign="middle"  rowspan="2"  >PSG</th><th align="center" valign="middle"  colspan="2"  >PLI</th><th align="center" valign="middle"  colspan="2"  >GI</th><th align="center" valign="middle"  colspan="2"  >CAL</th></tr></thead><tr><td align="center" valign="middle" >r</td><td align="center" valign="middle" >P-value</td><td align="center" valign="middle" >r</td><td align="center" valign="middle" >P-value</td><td align="center" valign="middle" >r</td><td align="center" valign="middle" >P-value</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >GI</td><td align="center" valign="middle"  rowspan="2"  >CI</td><td align="center" valign="middle" >N-KS</td><td align="center" valign="middle" >0.573</td><td align="center" valign="middle" >0.035</td><td align="center" valign="middle" >0.724</td><td align="center" valign="middle" >0.040</td><td align="center" valign="middle" >0.818</td><td align="center" valign="middle" >0.036</td></tr><tr><td align="center" valign="middle" >KS</td><td align="center" valign="middle" >0.276</td><td align="center" valign="middle" >0.015</td><td align="center" valign="middle" >0.229</td><td align="center" valign="middle" >0.021</td><td align="center" valign="middle" >0.481</td><td align="center" valign="middle" >0.041</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >GII</td><td align="center" valign="middle"  rowspan="2"  >CI</td><td align="center" valign="middle" >N-KS</td><td align="center" valign="middle" >0.602</td><td align="center" valign="middle" >0.007</td><td align="center" valign="middle" >0.811</td><td align="center" valign="middle" >0.011</td><td align="center" valign="middle" >0.516</td><td align="center" valign="middle" >0.013</td></tr><tr><td align="center" valign="middle" >KS</td><td align="center" valign="middle" >0.335</td><td align="center" valign="middle" >0.001</td><td align="center" valign="middle" >0.298</td><td align="center" valign="middle" >0.000</td><td align="center" valign="middle" >0.169</td><td align="center" valign="middle" >0.022</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >GIII</td><td align="center" valign="middle"  rowspan="2"  >CI</td><td align="center" valign="middle" >N-KS</td><td align="center" valign="middle" >0.246</td><td align="center" valign="middle" >0.023</td><td align="center" valign="middle" >0.447</td><td align="center" valign="middle" >0.036</td><td align="center" valign="middle" >0.691</td><td align="center" valign="middle" >0.024</td></tr><tr><td align="center" valign="middle" >KS</td><td align="center" valign="middle" >0.899</td><td align="center" valign="middle" >0.001</td><td align="center" valign="middle" >0.399</td><td align="center" valign="middle" >0.003</td><td align="center" valign="middle" >0.188</td><td align="center" valign="middle" >0.001</td></tr></tbody></table></table-wrap><p>G: Group, PLI: Plaque index, GI: Gingival index, CI: Calculus index, CAL: Clinical attachment loss.</p><p><xref ref-type="table" rid="table4">Table 4</xref> and <xref ref-type="fig" rid="fig3">Figure 3</xref> demonstrate the mean of salivary uric acid levels among the patients in the different groups (mg/dl) of the present study. The statistical analyses revealed statistically significant differences in the level of salivary uric acid in the comparison between kidney stones patients and non-kidney stones patients in group I and group III, whereas there were highly statistically significant in the comparison between kidney stones patients and non-kidney stones patients in group III.</p><p>The correlation between age and all clinical parameters were summarized in <xref ref-type="table" rid="table5">Table 5</xref>. There were statistically significant differences in the comparison between the age of patients and all clinical parameters except GI.</p><p>Regarding the correlation between the level of salivary uric acid and all clinical parameters, it is found to be statistically significant differences in the comparison between the level of salivary uric acid with PLI and GI whereas it was highly statistically significant in the comparison between the level of salivary uric acid with CI and CAL (<xref ref-type="table" rid="table6">Table 6</xref>).</p></sec><sec id="s4"><title>4. Discussion</title><p>Several studies showed the calcifications in the body (stones) with a decrease in the number of studies that tried to demonstrate the connection between these stones. These studies clarified that these stones have the same structure. Therefore, some of the studies considered their formation as metabolic disorders, and their components are identical in different organs [<xref ref-type="bibr" rid="scirp.103577-ref30">30</xref>] [<xref ref-type="bibr" rid="scirp.103577-ref31">31</xref>] [<xref ref-type="bibr" rid="scirp.103577-ref32">32</xref>]. In this retrospective study, the dental calculus formation was detected among most kidney stones patients more than non-kidney stones patients due to the kidneys’ work in an important way to organize the levels of uric acid in serum [<xref ref-type="bibr" rid="scirp.103577-ref33">33</xref>]. Similar to the study results of Davidovich E. et al. where they demonstrated that the calcium, phosphate, uric acid, and magnesium components in saliva play an important role in the association between kidney stones formation and, dental calculus formation. Furthermore, they found there was a relationship between the distribution of mineral metabolism and calculus formation among kidney disease patients [<xref ref-type="bibr" rid="scirp.103577-ref34">34</xref>].</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> The mean of salivary uric acid level among patients in different groups (mg/dl)</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Groups</th><th align="center" valign="middle"  rowspan="2"  ></th><th align="center" valign="middle"  rowspan="2"  >Mean &#177; SD</th><th align="center" valign="middle"  colspan="4"  >ANOVA</th></tr></thead><tr><td align="center" valign="middle" >F</td><td align="center" valign="middle" >P- value</td><td align="center" valign="middle" >F</td><td align="center" valign="middle" >P- value</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Group I</td><td align="center" valign="middle" >N-KS</td><td align="center" valign="middle" >1.98 &#177; 0.43</td><td align="center" valign="middle"  rowspan="2"  >0.615</td><td align="center" valign="middle"  rowspan="2"  >0.051</td><td align="center" valign="middle"  rowspan="6"  >0.302</td><td align="center" valign="middle"  rowspan="6"  >0.001</td></tr><tr><td align="center" valign="middle" >KS</td><td align="center" valign="middle" >2.54 &#177; 0.67</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Group II</td><td align="center" valign="middle" >N-KS</td><td align="center" valign="middle" >2.11 &#177; 0.31</td><td align="center" valign="middle"  rowspan="2"  >0.798</td><td align="center" valign="middle"  rowspan="2"  >0.002</td></tr><tr><td align="center" valign="middle" >KS</td><td align="center" valign="middle" >3.72 &#177; 0.70</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Group III</td><td align="center" valign="middle" >N-KS</td><td align="center" valign="middle" >2.71 &#177; 0.52</td><td align="center" valign="middle"  rowspan="2"  >0.751</td><td align="center" valign="middle"  rowspan="2"  >0.000</td></tr><tr><td align="center" valign="middle" >KS</td><td align="center" valign="middle" >5.81 &#177; 021</td></tr></tbody></table></table-wrap><p>G: group, SD: Standard deviation, N-KS: non-Kidney stones, KS: Kidney stones.</p><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> The Correlation between Age and all parameters</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Correlations</th><th align="center" valign="middle"  colspan="2"  >Age</th></tr></thead><tr><td align="center" valign="middle" >r</td><td align="center" valign="middle" >P-value</td></tr><tr><td align="center" valign="middle" >PLI</td><td align="center" valign="middle" >0.233</td><td align="center" valign="middle" >0.005*</td></tr><tr><td align="center" valign="middle" >GI</td><td align="center" valign="middle" >0.062</td><td align="center" valign="middle" >0.433</td></tr><tr><td align="center" valign="middle" >CI</td><td align="center" valign="middle" >0.03</td><td align="center" valign="middle" >0.003*</td></tr><tr><td align="center" valign="middle" >CAL</td><td align="center" valign="middle" >0.177</td><td align="center" valign="middle" >0.05*</td></tr></tbody></table></table-wrap><p>PLI: Plaque index, GI: Gingival index, CI: Calculus index, CAL: Clinical attachment loss. *statistically significant differences.</p><table-wrap id="table6" ><label><xref ref-type="table" rid="table6">Table 6</xref></label><caption><title> The Correlation between the level of salivary uric acid and all parameters</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Correlations</th><th align="center" valign="middle"  colspan="2"  >level of salivary uric acid</th></tr></thead><tr><td align="center" valign="middle" >r</td><td align="center" valign="middle" >P-value</td></tr><tr><td align="center" valign="middle" >PLI</td><td align="center" valign="middle" >0.714</td><td align="center" valign="middle" >0.004</td></tr><tr><td align="center" valign="middle" >GI</td><td align="center" valign="middle" >0.881</td><td align="center" valign="middle" >0.017</td></tr><tr><td align="center" valign="middle" >CI</td><td align="center" valign="middle" >0.136</td><td align="center" valign="middle" >0.000**</td></tr><tr><td align="center" valign="middle" >CAL</td><td align="center" valign="middle" >0.632</td><td align="center" valign="middle" >0.0001**</td></tr></tbody></table></table-wrap><p>PLI: Plaque index, GI: Gingival index, CI: Calculus index, CAL: Clinical attachment loss. **Highly statistically significant.</p><p>There was high plaque formation in the present study among kidney stones patients more than non-kidney stones patients, and dental calculus is dental plaque mineralization [<xref ref-type="bibr" rid="scirp.103577-ref18">18</xref>]. The result of the present study has supported this clarification that exhibited there was a correlation between the high value of PLI and an increase of calculus formation among kidney stones patients. Consequently, we evaluated the patients depending on the history of kidney stones, clinical examination of periodontal tissues and, assessment of calculus formation on the teeth surfaces with a uric acid level in saliva.</p><p>Results of the former study displayed that the prevalence of kidney stones is more among males (66%) than females and widespread within 31 - 40 years age group [<xref ref-type="bibr" rid="scirp.103577-ref35">35</xref>]. These results are appropriate with the objective of the present study that was done on 120 male Saudi patients within the age group (25 - 70) years, which included the age group (31 - 40) years. We explained to the patients the nature of calculus and, its impact on oral health and periodontal status moreover the possible correlation between calculus formation and the formation of kidney stones. According to previous studies, many researchers found significant links between kidney stones formation and accumulations of dental calculus on the teeth surfaces [<xref ref-type="bibr" rid="scirp.103577-ref34">34</xref>] [<xref ref-type="bibr" rid="scirp.103577-ref36">36</xref>]. Identical to the clinical findings in this study, we detected that there are significant correlations between kidney stones formation and dental calculus accumulations.</p><p>The current study and the study conducted by Brito et al. showed that GI and CAL were more in kidney stones patients group than non-kidney stones patients [<xref ref-type="bibr" rid="scirp.103577-ref37">37</xref>]. Consistent with the clinical findings of other studies revealed that periodontal destruction was more among kidney stones patients more than non-kidney stones patients [<xref ref-type="bibr" rid="scirp.103577-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.103577-ref38">38</xref>] [<xref ref-type="bibr" rid="scirp.103577-ref39">39</xref>] [<xref ref-type="bibr" rid="scirp.103577-ref40">40</xref>].</p><p>The higher mean values of GI, CI, and CAL among study group in the present study may be due to the higher mean values of PLI scores that recorded among kidney stones patients more than non-kidney stones patients in all study groups with statistical significance difference in all clinical parameters except GI among of kidney stones patients and CAL in kidney stones patients and non-kidney stones patients since dental plaque is the main etiological factor of periodontal diseases [<xref ref-type="bibr" rid="scirp.103577-ref41">41</xref>]. Xerostomia represents an oral complication of kidney stones disease and maybe predispose factors to gingival disease [<xref ref-type="bibr" rid="scirp.103577-ref42">42</xref>]. This is in agreement with the present study where the gingival disease was detected among all the kidney stones patients.</p><p>On the other hand, Uric acid is a major salivary antioxidant of healthy and diseased periodontal cases and there were many early studies comparing the salivary antioxidants levels among periodontitis patients and their levels in individuals with healthy periodontal tissues [<xref ref-type="bibr" rid="scirp.103577-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.103577-ref43">43</xref>]. Our results displayed the presence of a higher amount of salivary uric acid level in kidney stones patients compared to non-kidney stones patients. This result is supported by the results of other studies done by Hadi BA et al. (2011) and Xia Y et al. (2012) that displayed the levels of salivary uric acid in kidney stones patients were significantly higher than those of non-kidney stones patients [<xref ref-type="bibr" rid="scirp.103577-ref44">44</xref>] [<xref ref-type="bibr" rid="scirp.103577-ref45">45</xref>].</p><p>In the present study, there was an association between an increase of periodontal destruction and an increase in the level of salivary uric acid among kidney stones patients compared to non-kidney stones patients. Consequently, the present study demonstrated that there were highly significant differences in the dental calculus mean values among kidney stones patients than the non-kidney stones patients. This may be due to the presence of higher values of salivary uric acid level among kidney stones patients (mg/dl) compared to non-kidney stones patients in all study groups which corresponds to the results of other studies [<xref ref-type="bibr" rid="scirp.103577-ref46">46</xref>] [<xref ref-type="bibr" rid="scirp.103577-ref47">47</xref>]. Finally, many previous studies have tried to explain the relation between renal diseases in general, and the severity and type of periodontal diseases, but their findings were incompatible, that may be due to the massive debate in periodontal disease classification [<xref ref-type="bibr" rid="scirp.103577-ref48">48</xref>] - [<xref ref-type="bibr" rid="scirp.103577-ref53">53</xref>].</p></sec><sec id="s5"><title>5. Strength and Limitations</title><p>This study participates in the current efforts to explain the relationship between salivary uric acid levels and periodontal health among Kidney stones patients and non-Kidney stones patients. However, the cross-sectional nature of the study, self-reported medical conditions through medical history in the patient’s case sheet, participants’ consents and selection of study participants from the patients of a college of dentistry, King Khalid University, absence of female participants, and small sample size considered as limitations of the study.</p></sec><sec id="s6"><title>6. Conclusion</title><p>We studied the cases depending on the kidney stones’ history, dental calculus and periodontal status evaluation and salivary uric acid measurement where there was a statistically significant difference in dental calculus formation among patients with kidney stones more than non-kidney stones patients. This correlation between an increase of dental calculus formation and kidney stones formation in the current study may be due to the minerals that form the kidney stones that may be accumulate in other areas of the body. This may be evidence that dental calculus can form a diagnostic indicator to help in the detection and diagnosis of kidney stones in case of recurrence of dental calculus formation. Consequently, the detection of a dental calculus during the clinical examination may be considered a predictor of kidney stones present, and this conclusion should be subjected to more studies.</p></sec><sec id="s7"><title>Acknowledgements</title><p>The authors would like to thank all the participants in this study and the all staff in dental clinics, college of dentistry, King Khalid University for their help in the collection of data from the patients’ files.</p></sec><sec id="s8"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s9"><title>Cite this paper</title><p>Al-Abdaly, M.M.A.A., Alharbi, F.S.T., Almoalem, A.M. and Awaji, N.A.T. (2020) Paper Title. International Journal of Clinical Medicine, 11, 565-578. https://doi.org/10.4236/ijcm.2020.1110049</p></sec></body><back><ref-list><title>References</title><ref id="scirp.103577-ref1"><label>1</label><mixed-citation publication-type="book" xlink:type="simple">Phillip, D. (2015) The Role of Biofilms in Health and Disease. In: Kenneth, E. and Philip, O., Eds., Practical Periodontics, Elsevier Publishers, London, 51.</mixed-citation></ref><ref id="scirp.103577-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Marsh, P.D. (2004) Dental Plaque as a Microbial Biofilm. Caries Research, 38, 204-211. https://doi.org/10.1159/000077756</mixed-citation></ref><ref id="scirp.103577-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Miricescu, D., Grebu, M., Totan, A., Didilescu, A. and Radulescu, R. (2011) The Antioxidant Potential of Saliva: Clinical Significance in Oral Diseases. Therapeutics, Pharmacology and Clinical Toxicology, 15, 139-143.</mixed-citation></ref><ref id="scirp.103577-ref4"><label>4</label><mixed-citation publication-type="book" xlink:type="simple">Peter, S. (2004) Epidemiology Etiology and Prevention of Dental Caries. In: Peter, S., Ed., Essential of Preventive and Community Dentistry, 2nd Edition, Arya (Medi) Publishing House, New Delhi, 250-255.</mixed-citation></ref><ref id="scirp.103577-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Novakovic, N., Todorovic, T., Rakic, M., Milinkovic, I., Dozic, I., Jankovic, S., et al. (2014) Salivary Antioxidants as Periodontal Biomarkers in Evaluation of Tissue Status and Treatment Outcome. Journal of Periodontal Research, 49, 129-136. https://doi.org/10.1111/jre.12088</mixed-citation></ref><ref id="scirp.103577-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Dahiya, P., Kamal, R., Gupta, R., Bhardwaj, R., Chaudhary, K. and Kaur, S. (2013) Reactive Oxygen Species in Periodontitis. Journal of Indian Society of Periodontology, 17, 411-416. https://doi.org/10.4103/0972-124X.118306</mixed-citation></ref><ref id="scirp.103577-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Lippi, G., Montagnana, M., Franchini, M., Favaloro, E.J. and Targher, G. (2008) The Paradoxical Relationship between Serum Uric Acid and Cardiovascular Disease. Clinica Chimica Acta, 392, 1-7. https://doi.org/10.1016/j.cca.2008.02.024</mixed-citation></ref><ref id="scirp.103577-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Moore, S., Calder, K.A., Miller, N.J. and Rice-Evans, C.A. (1994) Antioxidant Activity of Saliva and Periodontal Disease. Free Radical Research, 21, 417-425. https://doi.org/10.3109/10715769409056594</mixed-citation></ref><ref id="scirp.103577-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Nagler, R.M., Klein, I., Zarzhevsky, N., Drigues, N. and Reznick, A.Z. (2002) Characterization of the Differentiated Antioxidant Profile of Human Saliva. Free Radical Biology and Medicine, 32, 268-277. https://doi.org/10.1016/S0891-5849(01)00806-1</mixed-citation></ref><ref id="scirp.103577-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Jenifer, H.D., Bhola, S., Kalburgi, V., Warad, S. and Kokatnur, V.M. (2015) The Influence of Cigarette Smoking on Blood and Salivary Super Oxide Dismutase Enzyme Levels among Smokers and Nonsmokers—A Cross Sectional Study. Journal of Traditional and Complementary Medicine, 5, 100-105. https://doi.org/10.1016/j.jtcme.2014.11.003</mixed-citation></ref><ref id="scirp.103577-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Friedlander, J.I., Moreira, D.M., Hartman, C., et al. (2014) Comparison of the Metabolic Profile of Mixed Calcium Oxalate/Uric Acid Stone Formers to That of Pure Calcium Oxalate and Pure Uric Acid Stone Formers. Urology, 84, 289-294. https://doi.org/10.1016/j.urology.2014.04.019</mixed-citation></ref><ref id="scirp.103577-ref12"><label>12</label><mixed-citation publication-type="book" xlink:type="simple">Reed, B. and Gitomer, W. (2007) The Genetics of Stone Disease. In: Stoller, M. and Meng, M., Eds., Urinary Stone Disease, Humena Press, Totowa, 35. https://doi.org/10.1007/978-1-59259-972-1_3</mixed-citation></ref><ref id="scirp.103577-ref13"><label>13</label><mixed-citation publication-type="book" xlink:type="simple">Pearle, M. and Lotan, Y. (2007) Urinary Lithiasis. In: Wein, A., Kavoussi, L., Novick, A., Partin, A. and Peters, C., Eds., Campbell-Walsh Urology, 9th Edition, Saunders, Philadelphia, 1363-1392.</mixed-citation></ref><ref id="scirp.103577-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Michel, D., Dominique, B. and Emmanuel, L. (2015) Randall’s Plaque as the Origin of Calcium Oxalate Kidney Stones. Urolithiasis, 43, 5-11. https://doi.org/10.1007/s00240-014-0703-y</mixed-citation></ref><ref id="scirp.103577-ref15"><label>15</label><mixed-citation publication-type="book" xlink:type="simple">Reilly, R. (2005) The Patient with Kidney Stones. In: Schrier, R., Ed., Manual of Nephrology, 6th Edition, Lippincott Williams and Wilkins, Philadelphia, 79-91.</mixed-citation></ref><ref id="scirp.103577-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">El-Faqih, S.R. (2012) Epidemiology of Stone Disease in Saudi Arabia with Overview of the Regional Differences. In: Urolithiasis, Springer-Verlag, London, 77-83. https://doi.org/10.1007/978-1-4471-4387-1_10</mixed-citation></ref><ref id="scirp.103577-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Tadakamadla, J., Kumar, S. and Mamatha, G.P. (2014) Comparative Evaluation of Oral Health Status of Chronic Kidney Disease (CKD) Patients in Various Stages and Healthy Controls. Special Care in Dentistry, 34, 122-126. https://doi.org/10.1111/scd.12040</mixed-citation></ref><ref id="scirp.103577-ref18"><label>18</label><mixed-citation publication-type="book" xlink:type="simple">Hinrichs, J. (2002) The Role of Dental Calculus and Other Predisposing Factors. In: Newman, M., Takei, H. and Carranza, F., Eds., Carranza’s Clinical Periodontology, 9th Edition, Saunders Company, Philadelphia, 182-187.</mixed-citation></ref><ref id="scirp.103577-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Sargolzaee, N., Najafi, M., Mohammad zadeh, M., Taheri, M. and Okati, B. (2007) The Evaluation of Calculus Rate in Patients with Nephrolithiasis. Journal of Mashhad Dental School, 31, 195-200.</mixed-citation></ref><ref id="scirp.103577-ref20"><label>20</label><mixed-citation publication-type="book" xlink:type="simple">Lang, N., Mombelli, A. and Attstrom, R. (2008) Oral Biofilm and Calculus. In: Lindhe, J., Lang, N. and Karring, T., Eds., Clinical Periodontology and Implant Dentistry, 5th Edition, Blackwell Munksgaard, Oxford, 197-202.</mixed-citation></ref><ref id="scirp.103577-ref21"><label>21</label><mixed-citation publication-type="book" xlink:type="simple">Stoller, M.L. (2008) Urinary Stone Disease. In: Tanagho, E.A. and McAninch, J.W., Eds., Smith’s General Urology, 17th Edition, McGraw Hill, New York, 246.</mixed-citation></ref><ref id="scirp.103577-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Faul, F., Erdfelder, E., Lang, A.G. and Buchner, A. (2007) G*Power 3: A Flexible Statistical Power Analysis Program for the Social, Behavioral, and Biomedical Sciences. Behavior Research Methods, 39, 175-191. https://doi.org/10.3758/BF03193146</mixed-citation></ref><ref id="scirp.103577-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Silness, J. and Loe, H. (1964) Periodontal Disease in Pregnancy II. Acta Odontologica Scandinavica, 22, 747-759. https://doi.org/10.3109/00016356408993968</mixed-citation></ref><ref id="scirp.103577-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Loe, H. and Silness, J. (1963) Periodontal Disease in Pregnancy I. Acta Odontologica Scandinavica, 21, 533-551. https://doi.org/10.3109/00016356309011240</mixed-citation></ref><ref id="scirp.103577-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Greene, J.C. and Vermillion, J.R. (1964) The Simplified Oral Hygiene Index. Journal of the American Dental Association, 68, 7-13. https://doi.org/10.14219/jada.archive.1964.0034</mixed-citation></ref><ref id="scirp.103577-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Chapple, I.L.C., Mealey, B.L., et al. (2018) Periodontal Health and Gingival Diseases and Conditions on an Intact and a Reduced Periodontium: Consensus Report of Workgroup 1 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. Journal of Clinical Periodontology, 45, S68-S77.</mixed-citation></ref><ref id="scirp.103577-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Caton, J., Armitage, G., Berglundh, T., et al. (2018) A New Classification Scheme for Periodontal and Periimplant Diseases and Conditions—Introduction and Key Changes from the 1999 Classification. Journal of Clinical Periodontology, 45, S1-S8. https://doi.org/10.1111/jcpe.12935</mixed-citation></ref><ref id="scirp.103577-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Papapanou, P.N., Sanz, M., et al. (2018) Periodontitis: Consensus Report of Workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. Journal of Clinical Periodontology, 45, S162-S170.</mixed-citation></ref><ref id="scirp.103577-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Navazesh, M. and Kumar, S.K. (2008) University of Southern California School of Dentistry. Measuring Salivary Flow: Challenges and Opportunities. Journal of the American Dental Association, 139, 35S-40S. https://doi.org/10.14219/jada.archive.2008.0353</mixed-citation></ref><ref id="scirp.103577-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Avogaro, A. and Fadini, G.P. (2015) Mechanisms of Ectopic Calcification: Implications for Diabetic Vasculopathy. Cardiovascular Diagnosis and Therapy, 5, 343-352.</mixed-citation></ref><ref id="scirp.103577-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Valenzuela, A. and Chung, L. (2015) Calcinosis: Pathophysiology and Management. Current Opinion in Rheumatology, 27, 542-548. https://doi.org/10.1097/BOR.0000000000000220</mixed-citation></ref><ref id="scirp.103577-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Aguilar-Ruiz, J., Arrabal-Polo, M.A., Sierra, M. and Arrabal-Martin, M. (2012) Application of Mineralogical Techniques in the Study of Human Lithiasis. Ultrastructural Pathology, 36, 367-376. https://doi.org/10.3109/01913123.2012.729879</mixed-citation></ref><ref id="scirp.103577-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Maiuolo, J., Oppedisano, F., Gratteri, S., Muscoli, C. and Mollace, V. (2016) Regulation of Uric Acid Metabolism and Excretion. International Journal of Cardiology, 213, 8-14. https://doi.org/10.1016/j.ijcard.2015.08.109</mixed-citation></ref><ref id="scirp.103577-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Davidovich, E., Davidovits, M., Peretz, B., et al. (2009) The Correlation between Dental Calculus and Disturbed Mineral Metabolism in Paediatric Patients with Chronic Kidney Disease. Nephrology Dialysis Transplantation, 24, 2439-2445. https://doi.org/10.1093/ndt/gfp101</mixed-citation></ref><ref id="scirp.103577-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Patel, A.C. and Mehta, N.H. (2014) Epidemiological Characteristics of Renal Stone Patients Age (21-60) and Barriers in Their Dietary Modification in Saurashtra Region. International Journal of Research in Medical Sciences, 2, 80-83. https://doi.org/10.5455/2320-6012.ijrms20140216</mixed-citation></ref><ref id="scirp.103577-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Shaimaa, K.Y. and Mohammed, S.A. (2012) Dental Calculus in Relation to Idiopathic Calcium Renal Stone. Journal of Baghdad College of Dentistry, 24, 140-145.</mixed-citation></ref><ref id="scirp.103577-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Brito, F., Almeida, S., Figueredo, C., Bregman, R., Suassuna, J. and Fischer, R. (2012) Extent and Severity of Chronic Periodontitis in Chronic Kidney Disease Patients. Journal of Periodontal Research, 47, 426-430. https://doi.org/10.1111/j.1600-0765.2011.01449.x</mixed-citation></ref><ref id="scirp.103577-ref38"><label>38</label><mixed-citation publication-type="other" xlink:type="simple">Nylund, K., Meurman, J., Heikkinen, A., Honkanen, E., Vesterinen, M. and Ruokonen, H. (2015) Oral Health in Predialysis Patients with Emphasis on Periodontal Disease. Quintessence International, 46, 899-907.</mixed-citation></ref><ref id="scirp.103577-ref39"><label>39</label><mixed-citation publication-type="other" xlink:type="simple">Tawig, A., Jamal, B., Eskandrani, R., Al Dayel, L., Al Twaijry, S., Al Ghamdi, E., et al. (2016) Assessment of Periodontal Disease Severity among Patients at Different Stages of Chronic Kidney Disease. Journal of International Oral Health, 8, 307-312.</mixed-citation></ref><ref id="scirp.103577-ref40"><label>40</label><mixed-citation publication-type="other" xlink:type="simple">Sharma, P., Dietrich, T., Ferro, C., Cockwell, P. and Chapple, I. (2016) Association between Periodontitis and Mortality in Stages 3-5 Chronic Kidney Disease: NHANES III and Linked Mortality Study. Journal of Clinical Periodontology, 43, 104-113. https://doi.org/10.1111/jcpe.12502</mixed-citation></ref><ref id="scirp.103577-ref41"><label>41</label><mixed-citation publication-type="other" xlink:type="simple">Gao, X., Deng, D. and Geng, Q.A. (2000) Study of Oral Health Condition in Individuals with No Oral Hygiene and Its Association with Plaque Acidogenesis. Chinese Journal of Dental Research, 3, 44-48.</mixed-citation></ref><ref id="scirp.103577-ref42"><label>42</label><mixed-citation publication-type="other" xlink:type="simple">Porter, S.R., Scully, C. and Hegarty, A.M. (2004) An Update of the Etiology and Management of Xerostomia. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 97, 28-46. https://doi.org/10.1016/j.tripleo.2003.07.010</mixed-citation></ref><ref id="scirp.103577-ref43"><label>43</label><mixed-citation publication-type="other" xlink:type="simple">Akalin, F.A., Baltacioglu, E., Alver, A. and Karabulut, E. (2007) Lipid Peroxidation Levels and Total Oxidant Status in Serum, Saliva and Gingival Crevicular Fluid in Patients with Chronic Periodontitis. Journal of Clinical Periodontology, 34, 558-565. https://doi.org/10.1111/j.1600-051X.2007.01091.x</mixed-citation></ref><ref id="scirp.103577-ref44"><label>44</label><mixed-citation publication-type="other" xlink:type="simple">Hadi, B.A. and Al-Jubouri, R.H. (2011) Salivary and Plasmaanalysis of Oxidative Stress Biomarkers in Endstage Renal Failure Patients. Journal of Baghdad College of Dentistry, 23, 46-50.</mixed-citation></ref><ref id="scirp.103577-ref45"><label>45</label><mixed-citation publication-type="other" xlink:type="simple">Xia, Y., Peng, C., Zhou, Z., Cheng, P., Sun, L., Peng, Y. and Xiao, P. (2012) Clinical Significance of Saliva Urea, Creatinine, and Uric Acid Levels in Patients with Chronic Kidney Disease. Journal of Central South University. Medical Sciences, 37, 1171-1176.</mixed-citation></ref><ref id="scirp.103577-ref46"><label>46</label><mixed-citation publication-type="other" xlink:type="simple">Brock, G.R., Butterworth, C.J., Matthews, J.B. and Chapple, I.L. (2004) Local and Systemic Total Antioxidant Capacity in Periodontitis and Health. Journal of Clinical Periodontology, 31, 515-521. https://doi.org/10.1111/j.1600-051X.2004.00509.x</mixed-citation></ref><ref id="scirp.103577-ref47"><label>47</label><mixed-citation publication-type="other" xlink:type="simple">Tsai, C.C., Chen, H.S., Chen, S.L., Ho, Y.P., Ho, K.Y., Wu, Y.M., et al. (2005) Lipidperoxidation: A Possible Role in the Induction and Progression of Chronic Periodontitis. Journal of Periodontal Research, 40, 378-384. https://doi.org/10.1111/j.1600-0765.2005.00818.x</mixed-citation></ref><ref id="scirp.103577-ref48"><label>48</label><mixed-citation publication-type="other" xlink:type="simple">Bayraktar, G., Kurtulus, I., Duraduryan, A., et al. (2007) Dental and Periodontal Findings in Hemodialysis Patients. Oral Diseases, 13, 393-397. https://doi.org/10.1111/j.1601-0825.2006.01297.x</mixed-citation></ref><ref id="scirp.103577-ref49"><label>49</label><mixed-citation publication-type="other" xlink:type="simple">Sakallioglu, E.E., Lutfioglu, O.M., Ozkaya, E., Aliyev, G., Acikgoz and Firatli, E. (2007) Fluid Dynamics of Gingiva and Gingival Health in Children with End Stage Renal Failure. Archives of Oral Biology, 52, 1194-1199. https://doi.org/10.1016/j.archoralbio.2007.05.004</mixed-citation></ref><ref id="scirp.103577-ref50"><label>50</label><mixed-citation publication-type="other" xlink:type="simple">Bayraktar, G., Kurtulus, R.I., Kazancioglu, et al. (2008) Evaluation of Periodontal Parameters in Patients Undergoing Peritoneal Dialysis or Hemodialysis. Oral Diseases, 14, 185-189. https://doi.org/10.1111/j.1601-0825.2007.01372.x</mixed-citation></ref><ref id="scirp.103577-ref51"><label>51</label><mixed-citation publication-type="other" xlink:type="simple">Davidovich, E., Schwarz, Z., Davidovitch, M., Eidelman, E. and Bimstein, E. (2005) Oral Findings and Periodontal Status in Children, Adolescents and Young Adults Suffering from Renal Failure. Journal of Clinical Periodontology, 32, 1076-1082. https://doi.org/10.1111/j.1600-051X.2005.00812.x</mixed-citation></ref><ref id="scirp.103577-ref52"><label>52</label><mixed-citation publication-type="other" xlink:type="simple">Fang, F., Wu, B., Qu, Q., et al. (2015) The Clinical Response and Systemic Effects of Non-Surgical Periodontal Therapy in End-Stage Renal Disease Patients: A 6-Month Randomized Controlled Clinical Trial. Journal of Clinical Periodontology, 42, 537-546. https://doi.org/10.1111/jcpe.12411</mixed-citation></ref><ref id="scirp.103577-ref53"><label>53</label><mixed-citation publication-type="other" xlink:type="simple">Almeida, S., Figueredo, C.M., Lemos, C., Bregman, R. and Fischer, R.G. (2017) Periodontal Treatment in Patients with Chronic Kidney Disease: A Pilot Study. Journal of Periodontal Research, 52, 262-267. https://doi.org/10.1111/jre.12390</mixed-citation></ref></ref-list></back></article>